Physician profile
Jaime Wang
NPI 1538713672
$1,953.88
in general payments reported to CMS, 2019-2025
19 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.12 · 2020: $137 · 2021: $827 · 2022: $579 · 2023: $155 · 2024: $53.44 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $393.08 | 2021-2022 | |
| Alcon Vision LLC | $244.38 | 2021-2025 | Clareon, Tryptyr, Dailies |
| Alimera Sciences, INC. | $196.44 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $177.59 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $131.49 | 2020-2021 | |
| Johnson & Johnson Vision Care, INC. | $125.00 | 2021 | |
| Allergan, INC. | $106.57 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $105.17 | 2019-2023 | Cequa |
| Novartis Pharmaceuticals Corporation | $81.41 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $70.77 | 2021 | |
| Abbvie INC. | $68.97 | 2022-2024 | |
| Coopervision INC. | $68.86 | 2023 | Misight Contact Lens |
| Bausch & Lomb Americas INC. | $39.66 | 2022-2024 | Miebo, Xiidra |
| Regeneron Healthcare Solutions, INC. | $29.22 | 2021 | |
| Oyster Point Pharma, INC. | $26.76 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $26.09 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $25.90 | 2023 | Whitestar Phaco Handpiece |
| Dompe US, INC. | $21.72 | 2022 | |
| Mallinckrodt Enterprises LLC | $14.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.